Document Classification

Section Type: RESULTS

Text: Treatment with GH produced a significant reduction in plasma TNF-alpha (7. 8 + / -1. 1 vs 5. 5 + / -0. 9 pg/ml, P = 0. 013), IL-6 (5. 7 + / -0. 5 vs 4. 7 + / -0. 4 pg/ml, P = 0. 043), GM-CSF (27. 3 + / -1. 7 vs 23. 3 + / -1. 8 pg/ml, P = 0. 042), sGM-CSFR (4. 0 + / -0. 4 vs 3. 2 + / -0. 4 ng/ml, P = 0. 039), MCP-1 (199 + / -5 vs 184 + / -6 pg/ml, P = 0. 048), sICAM-1 (324 + / -34 vs 274 + / -27 ng/ml, P = 0. 008) and sVCAM-1 (1238 + / -89 vs 1043 + / -77 ng/ml, P = 0. 002) in DCM patients.